Vaccine comprising live attenuated or inactivated rotavirus strains; HRV 89-12C2, HRV 408, HRV 248 HRV 456 and/or CJN, for immunization against rotavirus illnesses

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 1992
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131017/
http://dx.doi.org/10.1016/0264-410X(92)90122-Z
_version_ 1783517141760212992
collection PubMed
description
format Online
Article
Text
id pubmed-7131017
institution National Center for Biotechnology Information
language English
publishDate 1992
publisher Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71310172020-04-08 Vaccine comprising live attenuated or inactivated rotavirus strains; HRV 89-12C2, HRV 408, HRV 248 HRV 456 and/or CJN, for immunization against rotavirus illnesses Vaccine Patent Report Published by Elsevier Ltd. 1992 2002-11-13 /pmc/articles/PMC7131017/ http://dx.doi.org/10.1016/0264-410X(92)90122-Z Text en © 1992 Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Patent Report
Vaccine comprising live attenuated or inactivated rotavirus strains; HRV 89-12C2, HRV 408, HRV 248 HRV 456 and/or CJN, for immunization against rotavirus illnesses
title Vaccine comprising live attenuated or inactivated rotavirus strains; HRV 89-12C2, HRV 408, HRV 248 HRV 456 and/or CJN, for immunization against rotavirus illnesses
title_full Vaccine comprising live attenuated or inactivated rotavirus strains; HRV 89-12C2, HRV 408, HRV 248 HRV 456 and/or CJN, for immunization against rotavirus illnesses
title_fullStr Vaccine comprising live attenuated or inactivated rotavirus strains; HRV 89-12C2, HRV 408, HRV 248 HRV 456 and/or CJN, for immunization against rotavirus illnesses
title_full_unstemmed Vaccine comprising live attenuated or inactivated rotavirus strains; HRV 89-12C2, HRV 408, HRV 248 HRV 456 and/or CJN, for immunization against rotavirus illnesses
title_short Vaccine comprising live attenuated or inactivated rotavirus strains; HRV 89-12C2, HRV 408, HRV 248 HRV 456 and/or CJN, for immunization against rotavirus illnesses
title_sort vaccine comprising live attenuated or inactivated rotavirus strains; hrv 89-12c2, hrv 408, hrv 248 hrv 456 and/or cjn, for immunization against rotavirus illnesses
topic Patent Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131017/
http://dx.doi.org/10.1016/0264-410X(92)90122-Z